Issue navigation
Volume 27, Issue 2, February 2025
Obituary
In memoriam: Massimo Santini
Giuseppe Boriani
EP Europace, Volume 27, Issue 2, February 2025, euaf028, https://doi.org/10.1093/europace/euaf028
Editorials
Freeze the clock: earlier catheter ablation for atrial fibrillation delivers better outcomes
Marco Schiavone and Luigi Di Biase
EP Europace, Volume 27, Issue 2, February 2025, euaf010, https://doi.org/10.1093/europace/euaf010
Pulmonary vein reconnection rates after pulse field ablation: time for a reality check?
Alessio Gasperetti and Luigi Di Biase
EP Europace, Volume 27, Issue 2, February 2025, euaf014, https://doi.org/10.1093/europace/euaf014
Ventricular tachycardia functional substrate targeting: a standalone strategy for all?
Antonio Berruezo and others
EP Europace, Volume 27, Issue 2, February 2025, euaf004, https://doi.org/10.1093/europace/euaf004
The evolving epidemiological landscape of atrial fibrillation: trends, challenges, and opportunities for improved patient care
Marco Zuin and others
EP Europace, Volume 27, Issue 2, February 2025, euaf026, https://doi.org/10.1093/europace/euaf026
Clinical Research
Prognostic relevance of baseline exercise stress test in RYR2-related CPVT
Deni Kukavica and others
EP Europace, Volume 27, Issue 2, February 2025, euae294, https://doi.org/10.1093/europace/euae294
Impact of atrial fibrillation diagnosis-to-ablation time on 24-month efficacy and safety outcomes in the Cryo Global Registry
Dennis Lawin and others
EP Europace, Volume 27, Issue 2, February 2025, euaf008, https://doi.org/10.1093/europace/euaf008
Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank
C Fielder Camm and others
EP Europace, Volume 27, Issue 2, February 2025, euae291, https://doi.org/10.1093/europace/euae291
The risk of failure of subcutaneous implantable cardioverter defibrillator therapy: from PRAETORIAN score to clinical practice
Matteo Ziacchi and others
EP Europace, Volume 27, Issue 2, February 2025, euaf011, https://doi.org/10.1093/europace/euaf011
Improving atrial fibrillation or flutter detection and management by smartphone-based photoplethysmography rhythm monitoring following cardiac surgery: a pragmatic randomized trial
Henri Gruwez and others
EP Europace, Volume 27, Issue 2, February 2025, euaf015, https://doi.org/10.1093/europace/euaf015
First-in-human trial of atrial fibrillation ablation using real-time tissue optical assessment to predict pulsed field lesion durability
Raphael P Martins and others
EP Europace, Volume 27, Issue 2, February 2025, euaf009, https://doi.org/10.1093/europace/euaf009
Comparative analysis of anaesthesia modalities in pulmonary vein isolation: insights from a prospective multicentre registry
Eias Massalha and others
EP Europace, Volume 27, Issue 2, February 2025, euae301, https://doi.org/10.1093/europace/euae301
SCN5A variant type-dependent risk prediction in Brugada syndrome
Takanori Aizawa and others
EP Europace, Volume 27, Issue 2, February 2025, euaf024, https://doi.org/10.1093/europace/euaf024
Evoked delayed potential ablation for post-myocardial infarction ventricular tachycardia: results from a large prospective multicentre study
Marta de Riva and others
EP Europace, Volume 27, Issue 2, February 2025, euaf003, https://doi.org/10.1093/europace/euaf003
Left atrial intramyocardial fat at pulmonary vein reconnection sites during atrial fibrillation redo ablation
Federico Landra and others
EP Europace, Volume 27, Issue 2, February 2025, euaf038, https://doi.org/10.1093/europace/euaf038
Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046—a systematic analysis of the Global Burden of Disease Study 2021
Siyuan Tan and others
EP Europace, Volume 27, Issue 2, February 2025, euaf027, https://doi.org/10.1093/europace/euaf027
Early versus late atrial fibrillation recurrence after pulsed field ablation: insights from the admIRE trial
Luigi Di Biase and others
EP Europace, Volume 27, Issue 2, February 2025, euaf007, https://doi.org/10.1093/europace/euaf007
Landiolol is effective and safe in paediatric supraventricular tachycardia: evidence from a European prospective multicentre open-label phase III study (LANDI-PED)
Ina Michel-Behnke and others
EP Europace, Volume 27, Issue 2, February 2025, euaf025, https://doi.org/10.1093/europace/euaf025
Translational Research
Lactobacillus gasseri prevents ibrutinib-associated atrial fibrillation through butyrate
Ling Shi and others
EP Europace, Volume 27, Issue 2, February 2025, euaf018, https://doi.org/10.1093/europace/euaf018
Decreased METTL3 in atrial myocytes promotes atrial fibrillation
Jian Shi and others
EP Europace, Volume 27, Issue 2, February 2025, euaf021, https://doi.org/10.1093/europace/euaf021
A computational study on the influence of antegrade accessory pathway location on the 12-lead electrocardiogram in Wolff–Parkinson–White syndrome
Karli Gillette and others
EP Europace, Volume 27, Issue 2, February 2025, euae223, https://doi.org/10.1093/europace/euae223
Research Letters
Atrial fibrillation screening for stroke prevention: an instrumental variables meta-analysis addressing varying participation rates
Carl Bonander and others
EP Europace, Volume 27, Issue 2, February 2025, euaf030, https://doi.org/10.1093/europace/euaf030
Intracardiac echocardiography-guided discrete potential mapping for arrhythmias from right ventricular outflow tract
Nanqing Xiong and others
EP Europace, Volume 27, Issue 2, February 2025, euaf033, https://doi.org/10.1093/europace/euaf033
Mortality and use of implantable cardioverter defibrillators in patients with low ejection fraction following non-ST-segment elevation myocardial infarction
Nina Stødkilde-Jørgensen and others
EP Europace, Volume 27, Issue 2, February 2025, euaf036, https://doi.org/10.1093/europace/euaf036
Letters to the Editor
Letter to the editor: exercise stress test as a screening tool for pre-excitation
Marcos Clavero-Adell and others
EP Europace, Volume 27, Issue 2, February 2025, euaf013, https://doi.org/10.1093/europace/euaf013
The crucial importance of preventive and cardiac rehabilitation programmes in patients with atrial fibrillation: AF-CARE units
Ercan Akşit and others
EP Europace, Volume 27, Issue 2, February 2025, euaf016, https://doi.org/10.1093/europace/euaf016
Global inequalities of atrial fibrillation/atrial flutter from 1990 to 2021: study based on Global Burden of Disease 2021
Mengting Liu and others
EP Europace, Volume 27, Issue 2, February 2025, euaf020, https://doi.org/10.1093/europace/euaf020
Corrections
Correction to: Cardioneuroablation for the treatment of reflex syncope and functional bradyarrhythmias: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS) and the Latin American Heart Rhythm Society (LAHRS)
EP Europace, Volume 27, Issue 2, February 2025, euaf023, https://doi.org/10.1093/europace/euaf023
Correction to: Acute and mid-term outcomes of ablation for atrial fibrillation with VISITAG SURPOINT: the Japan MIYABI registry
EP Europace, Volume 27, Issue 2, February 2025, euae261, https://doi.org/10.1093/europace/euae261
Correction to: Multipoint pacing is associated with improved prognosis and cardiac resynchronization therapy response: MORE-CRT MPP randomized study secondary analyses
EP Europace, Volume 27, Issue 2, February 2025, euaf022, https://doi.org/10.1093/europace/euaf022
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals